Blog

Photo taken from Dana Narvaez/X

Aug 27, 2024, 17:52

Upcoming ESMO Young Oncologists session

Dana Narvaez, Oncology Fellow at Alexander Fleming Institute, shared on X:

“Upcoming ESMO Young Oncologists session: How to conduct clinical trials in resource-limited settings with Pablo Mando. Don’t miss it!”

Source: Dana Narvaez/X

Alexander Fleming Institute cancer clinical trials Dana Narvaez ESMO ESMO Young Oncologists OncoDaily Oncology pablo mando

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Jan 20, 2025, 15:41

Endoscopic Ultrasound Gastroenterostomy versus Duodenal Stenting for Malignant GOO

Science

Jan 20, 2025, 15:25

Tony Hung: A virtual integrative medicine program to improve symptoms and decrease hospitalization

Blog

Jan 20, 2025, 14:46

Gregg Margolis: Three things to read about health policy this week

Blog

Jan 20, 2025, 14:43

Afreen Shariff: Excellent to connect with fellow board members at the ACCC

Dialogues

Jan 20, 2025, 14:32

The Current Situation with Colorectal Cancer in Kazakhstan

Science

Jan 20, 2025, 14:17

Hung Trinh: Bispecific Antibodies in Cancer Therapy

Insight

Jan 20, 2025, 14:16

Amy Moore: Ensuring that all patients benefit from recent scientific advances in lung cancer

Blog

Jan 20, 2025, 14:04

Emily Drake: I finally joined Bluesky

Insight

Jan 20, 2025, 14:03

Richard Sullivan reflects on major issues cancer care faces in radiotherapy

Blog

Jan 20, 2025, 13:56

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Blog

Jan 20, 2025, 13:56

Luis Felipe Tapias: It has been 4 years since I started as a Thoracic Surgeon at Mayo Clinic

Opinion

Jan 20, 2025, 13:56

Amol Akhade: Do oncologists from LMICs and HICs treat and read about only certain solid tumors or all of them?